Paroxysmal Monomorphic Ventricular Tachycardia (PMVT)
Paroxysmal Monomorphic Ventricular Tachycardia (PMVT) is a cardiac arrhythmia characterized by three or more consecutive ventricular complexes occurring at a rate greater than 100 beats per minute with a single stable QRS morphology, which starts and terminates abruptly. 1
Definition and Characteristics
- PMVT is classified as a ventricular tachycardia (VT) with a single QRS morphology (monomorphic) that starts and stops suddenly (paroxysmal) 1
- VT is defined as a cardiac arrhythmia of three or more consecutive complexes emanating from the ventricles at a rate greater than 100 bpm (cycle length less than 600 ms) 1
- PMVT can be further categorized as nonsustained (lasting less than 30 seconds and terminating spontaneously) or sustained (lasting more than 30 seconds or requiring termination due to hemodynamic compromise) 1
Clinical Presentation
- Patients may be hemodynamically stable or unstable depending on the duration, rate, and underlying cardiac function 1
- Symptoms range from asymptomatic to severe and may include:
- PMVT differs from polymorphic VT, which has a changing or multiform QRS morphology 1
Mechanisms
- The most common mechanism for monomorphic VT is re-entry, where electrical impulses circulate around a fixed obstacle in a defined circuit 1
- Other mechanisms include:
- In outflow tract VT (a common form of monomorphic VT), the mechanism is often related to triggered activity arising from delayed afterdepolarizations dependent on intracellular calcium overload 1
Diagnostic Evaluation
- 12-lead ECG during tachycardia is essential for diagnosis 1
- ECG characteristics include:
- Regular rhythm at >100 bpm
- Wide QRS complexes (>120 ms)
- Consistent QRS morphology throughout the episode
- Absence of associated P waves or AV dissociation 1
- Electrophysiological testing may be reasonable for diagnostic evaluation in patients with structurally normal hearts with suspected VT 1
Management
Treatment depends on hemodynamic stability:
Medical management options include:
- Procainamide (Class IIa recommendation): 10 mg/kg IV at 50-100 mg/min over 10-20 minutes with monitoring 1, 3
- Amiodarone (Class IIb recommendation): for patients with heart failure or suspected ischemia 1
- Sotalol (Class IIb recommendation): may be considered for patients with hemodynamically stable sustained monomorphic VT 1
Long-term management:
- Catheter ablation is useful in patients with symptomatic, drug-refractory VT or in those who do not desire long-term drug therapy 1
- ICD implantation can be effective for termination of sustained VT in patients with normal or near-normal ventricular function who are receiving optimal medical therapy 1
Prognosis
- Prognosis varies based on:
- Presence of structural heart disease
- Left ventricular function
- Underlying etiology 1
- PMVT in structurally normal hearts generally has a better prognosis than in those with structural heart disease 1, 3
Important Distinctions
- PMVT must be distinguished from polymorphic VT (which has changing QRS morphology) and torsades de pointes (polymorphic VT associated with long QT interval) 1, 4
- Unlike supraventricular tachycardias, PMVT originates from the ventricles rather than atrial tissue or AV node 1
- The presence of irregular cannon A waves and/or irregular variation in S1 intensity during a regular tachycardia strongly suggests ventricular origin 1
Clinical Pearls and Pitfalls
- Not all wide-complex tachycardias are ventricular in origin; supraventricular tachycardias with aberrant conduction can mimic VT 1
- The presence of AV dissociation strongly supports the diagnosis of VT 1
- PMVT with hemodynamic stability should not be mistaken for a benign condition, especially in patients with structural heart disease 1
- Outflow tract VT (commonly from right ventricular outflow tract) is the most common form of VT in apparently healthy people and generally has a good prognosis 1